Milan Hospital Trials Alter-Ego Robot to Support ALS Patients

Alter-Ego Robot Undergoes Testing in Milan

According to НВ — Техно: Standing 1.2 meters tall, the Alter-Ego robot is being trialed at Milan's Maugeri Hospital to assist individuals with amyotrophic lateral sclerosis (ALS). This initiative stems from a collaboration between the Italian Institute of Technology and the University of Pisa. Testing kicked off in April 2026, with the robot currently operated remotely by a human controller. However, starting in July 2026, Alter-Ego is slated to operate autonomously.

The trial participant, 31-year-old Daniele Senna, is among the first to use this robotic device. Manuel Catalano of the Italian Institute of Technology noted that Alter-Ego could eventually help patients at home, simplifying their daily routines.

Medical Innovations and Cautious Optimism

Dr. Cristian Lunetta, head of the hospital's neuromotor rehabilitation unit, expressed concerns about potential negative patient reactions to the new device. Nevertheless, neurologist Raquel Piras emphasized that delegating tasks like administering pills to the robot was never considered, reflecting a careful approach to integrating technology into medical care.

Earlier, NV Tech reported on a 0.96 kg robotic knee device that aided children with spinal muscular atrophy (SMA). These advancements highlight a growing trend in using robotics to treat various conditions and enhance patient quality of life.

The Milan trial of Alter-Ego could mark a pivotal step in robotic healthcare technology. If successful, it may unlock new ways to improve life for ALS patients and those with other neurological disorders. The increasing use of robotics in medicine underscores the importance of innovation in healthcare, offering not just treatment but also greater independence for patients in their everyday lives.

As the landscape of robotic assistance in healthcare evolves, recent developments like the robotic device that helps children regain mobility illustrate the potential of technology to transform patient care. These innovations not only address specific medical needs but also pave the way for greater independence among patients, making the ongoing trials in Milan a significant step forward in this field.